ライフサイエンスコーパス: serological

1 8 screening in both donors and recipients, 6 serological (4 indirect immunofluorescent assays [IFA] a

2 nosis but can be recommended for determining serological activity and the effect of syphilis treatmen

3 s through telephone interviews and performed serological analyses of specific immunoglobulin E reacti

4 Serological analyses, gene expression profiling and live

5 Serological analysis and isolation of murine monoclonal

6 e investigated this hypothesis further using serological analysis, an immunological measure of past e

7 nd 33X2 express novel capsule types based on serological and biochemical analyses.

8 Serological and biochemical studies also supported a dia

9 Paraneoplastic serological and cerebrospinal fluid evaluations revealed

10 omal HAV vaccine in 2005, followed by yearly serological and clinical assessments until 2012.

11 ional test results was assessed according to serological and clinical categories.

12 Histological, serological and clinical characteristics were compared b

13 Cross-sectional clinical, serological and functional analysis in 25 consecutive pa

14 cal and reference isolates and studied their serological and genetic properties, as well as the struc

15 Advances in MRI and serological and genetic testing have greatly increased a

16 Our goal was to define clinical, serological and histopathological findings in a large co

17 alised equipment, and expensive reagents for serological and molecular diagnosis respectively.

18 capsular and pilus types were identified by serological and molecular methods.

19 We performed serological and molecular pretransplant screening in sol

20 Serological and molecular techniques (detection of hepat

21 sing hepatitis, using commercially available serological and nucleic acid assays.

22 Despite this she achieved an excellent serological and radiological response that was maintaine

23 d we compare predictions between models with serological and sequence data.

24 We used serological and surveillance data to estimate the probab

25 throughout the HPV research community in HPV serological and vaccine development and to define mechan

26 of this study was to elucidate the clinical, serological, and genetic features of remission, relapse,

27 e research should aim to establish clinical, serological, and imaging biomarkers to identify high-ris

28 gh most ecological immunology studies employ serological antibody assays, endpoint titre determinatio

29 the preexisting memory B cell repertoire and serological antibody levels must be taken into considera

30 Here, we demonstrate that high preexisting serological antibody levels to a given influenza virus s

31 Allergic responses, serological antibody levels, intestinal histology and sy

32 r-level based on the direct determination of serological antibody repertoire.

33 Overall, the systematic serological approach described here aimed at broadly cap

34 uses and their cocirculation has complicated serological approaches to differentially detect ZIKV and

35 sis antigens using a field-based multiplexed serological assay and a 132-antigen bead-based reference

36 that antigenic differences measured through serological assay data are well described by a sum of an

37 develop methods to reduce the lead time for serological assay development.

38 iferase-ZIKV- and -dengue virus (DENV)-based serological assay, which considerably improves the turna

39 ens, and compared to the results of standard serological assays (C6, ELISA, and Western blot).

40 Serological assays and a two-tiered test algorithm are r

41 gative results for WNV by current RT-PCR and serological assays and the absence of clinical signs of

42 tential to underpin the development of novel serological assays and vaccines.

43 Serological assays are not routinely used in the diagnos

44 Robust serological assays capable of detecting antibodies in HP

45 These mutations can potentially confound serological assays commonly used to identify antigenical

46 Serological assays demonstrated that vaccine-induced ser

47 Both molecular and serological assays have been used previously to determin

48 useful in reducing the development time for serological assays in the face of an infectious disease

49 udy of elderly inhabitants of Kinshasa, with serological assays, amplification, and sequencing.

50 Mycoplasma infection, including cultivation, serological assays, and PCR, are time-consuming and requ

51 n combination with findings of molecular and serological assays, can discriminate between acute and p

52 Serological assays, specifically lytic IFAs, were the be

53 In this study, using newly established serological assays, we demonstrated evidence of shrew-bo

54 utination inhibition and microneutralization serological assays.

55 the speed and sensitivity of virological and serological assays.

56 and by constructing MERS-CoV S variants for serological assays.

57 tween clinical forms and positive results of serological assays.

58 SF for both WNV RNA by RT-PCR and WNV IgM by serological assays.

59 ts frequency, and clinical, oncological, and serological associations.

60 of the genetic, biochemical structural, and serological bases of serotypes 35C and 42.

61 e antigen, named sTRA, that is as accurate a serological biomarker of pancreatic cancer as the cancer

62 For the first time, we show that CF specific serological biomarkers can be identified through immunoc

63 ciated biomarkers are three major classes of serological biomarkers with GC warning potential, joint

64 Serological breakthrough (i.e., reappearance of HBsAg) i

65 Serological breakthrough infection (7106 mIU/mL) was doc

66 allergy tested positive for both genetic and serological CD markers, while the prevalence among the s

67 Here we comprehensively characterize serological, cellular and functional immune parameters o

68 ytic anemia (AIHA) cases and correlated with serological characteristics and severity of anemia at on

69 yping assay is a critical test to ensure the serological compatibility of a donor and an intended rec

70 performance in a simple 1-tier test for the serological confirmation of LD.

71 The most reliable test method for the serological confirmation of Lyme disease (LD) is a 2-tie

72 The serological conservation of infected erythrocytes strong

73 However, we found no association between serological conservation per se and disease severity wit

74 clinical P. falciparum samples, we measured serological conservation using pools of antibodies in se

75 The CMV donor or recipient serological constellation also predicted the incidence o

76 Virus detection and serological conversion have been the main targets of dia

77 eristics, measles vaccine effectiveness, and serological correlates for protection.

78 ease aetiologies, poor longitudinal clinical-serological correlations and a limited immunotherapy res

79 biopsy provided that strict symptomatic and serological criteria are met.

80 nd Drug Administration (FDA) on the basis of serological criteria.

81 Here we investigated the serological cross-reaction between the two viruses.

82 Because of the serological cross-reactivity among the flaviviruses, mol

83 The absence of serological cross-reactivity between rVSV and rISFV and

84 Serological cure (including seroreversion or a fourfold

85 The primary endpoint was serological cure, defined as a two-dilution decrease in

86 virus characterizations were performed using serological data from humans with primary influenza A(H3

87 alculated the basic reproduction number from serological data in settings with high, medium, and low

88 cells have not been demonstrated, the canine serological data indicate that dogs produce an immune re

89 NGS data in addition to limited serological data provided strong diagnostic evidence tha

90 of strain A-85/14 combined with the previous serological data show the existence of a sixteenth serov

91 Finite mixture modeling can be applied to serological data to obtain estimates of the proportion o

92 excess fraction (PEF), can be estimated from serological data using finite mixture modeling.

93 nfection, sociodemographic, obstetrical, and serological data were analyzed.

94 hese epidemics, comparing human and ruminant serological data with environmental and cattle-trade dat

95 ses is higher than previous population-level serological data would suggest.

96 esigned to examine a 12-y, longitudinal DENV serological dataset from Iquitos, Peru (11,703 individua

97 ess these questions by analyzing a long-term serological dataset of CDV in lions and domestic dogs fr

98 ed turnaround times, and can be used for the serological detection of ZIKV infections.

99 NP is also the exclusive target for the serological diagnoses.

100 Serological diagnosis is potentially an effective tool f

101 and the potential for its routine use in the serological diagnosis of ATL.

102 The serological diagnosis of celiac disease (CD) often relie

103 rence assays are available for molecular and serological diagnosis of CHIKV infections.

104 a-d-Glucan (BDG) testing is FDA approved for serological diagnosis of invasive fungal disease; howeve

105 native reference test to the IgM IFA for the serological diagnosis of scrub typhus.

106 need for multiplexed assay platforms, as the serological diagnosis of T. gondii infection does not re

107 ny diagnostic tests that are employed in the serological diagnosis of this infection.

108 in the envelope proteins, can complicate the serological diagnosis of Zika virus (ZIKAV) infection.

109 Serological diagnosis plays a crucial role in the identi

110 Based on clinical presentation and serological diagnosis, all reported SHF outbreaks were t

111 mes higher sensitivity than the conventional serological diagnosis.

112 t transistor (FET) for direct potentiometric serological diagnosis.

113 The current serological diagnostic method can be time consuming and

114 The limited availability of rapid serological diagnostic tests hinders rapid diagnosis and

115 ely ZIKV-specific and were used to develop a serological diagnostic tool.

116 tection, pooled sampling, and a hypothetical serological diagnostic-were simulated and evaluated for

117 re (POC) devices are the next generation for serological disease diagnosis.

118 Serological documentation of maternal exposure to influe

119 ay [SRA]) has been recommended as the target serological end point to permit safe surgery.

120 ecular (polymerase chain reaction [PCR]) and serological (enzyme-linked immunosorbent assay) analyses

121 Sensitive serological evaluation for AQP4-IgG in this large popula

122 Serological evaluation of immunity to VZV will help dete

123 s are small, and provide a powerful tool for serological evaluation of malaria transmission intensity

124 lasmodium falciparum parasite prevalence and serological evidence for exposure.

125 However, serological evidence of acute herpesvirus infection doub

126 reports of two novel IAVs in fruit bats and serological evidence of avian influenza virus (AIV) H9 i

127 ; roughly 30% of the world's population show serological evidence of current or past infection.

128 6, about 40% of females and 20% of males had serological evidence of exposure to >/=1 of 9 HPV types.

129 [81%] vs 809/1084 [75%], p=0.003) and having serological evidence of herpes (612/791 [77%] vs 613/812

130 Studies reporting serological evidence of human influenza A(H9N2) infectio

131 zation (WHO)-recommended case definition for serological evidence of infection based on results of he

132 An algorithm developed a priori classified serological evidence of past and acute herpesvirus infec

133 Serological evidence of past infection did not differ be

134 t identified in stool samples from 248 dogs, serological evidence of previous exposure to HuNoV was o

135 nd the number of persons (mainly young) with serological evidence of vaccine protection from HBV infe

136 We showed serological evidence that antibodies to two genetically

137 Fortunately, there was sparse serological evidence that the virus was infecting poultr

138 io at baseline, and negative cytomegalovirus serological findings.

139 with throat viral load, fever duration, and serological genogroup-specific neutralization titer.

140 The serological hallmark of primary biliary cirrhosis is the

141 ed immunosorbent assays (ELISA) which tested serological HBV markers were applied.

142 orrelation between subjective complaints and serological histamine parameters in patients with suspec

143 Molecular understanding of serological immunity to influenza has been confounded by

144 h-affinity antibodies required for long-term serological immunity.

145 a covalent linkage between ECA and LPS; only serological indications of co-association have been repo

146 ite prevalence on anti-Plasmodium falciparum serological indicators in pregnant women varies by setti

147 We observed heterogeneity in serological indices across study sites in Lake Victoria.

148 However, maternal serological influenza exposure was related to a signific

149 Literature reviews on serological information for both primary vaccine failure

150 Ghrelin serological levels were significantly induced in Hnf1alp

151 antibody (ANNA-1, anti-Hu) specificity is a serological marker of paraneoplastic neurological autoim

152 nt disease development and could represent a serological marker to help guide therapeutic decision ma

153 A reliable serological marker to monitor venom immunotherapy (VIT)

154 tify diagnostic values of the most promising serological markers (Cor a 9 and Cor a 14) and to addres

155 HBV infection as the presence of any of HBV serological markers (hepatitis B surface antigen, anti-h

156 specimens were characterized for HBV DNA and serological markers and 39 cytokines.

157 een groups and correlation between clinical, serological markers and imaging findings was undertaken.

158 ring allergen-specific basophil response and serological markers in 20 subjects with moderate-to-seve

159 bited body weight gain and modulated several serological markers including cholesterol, triglyceride,

160 dynamics assessed with echocardiography, and serological markers of endothelial activation were deter

161 ue inflammation correlates with clinical and serological markers of inflammation.

162 ctural protein 1 (NS1) have been proposed as serological markers of natural infections among vaccinat

163 Our aim was to find reliable serological markers to predict tolerance to bee and vesp

164 iteria for SS utilize anti-Ro and anti-La as serological markers.

165 artly double-stranded DNA virus with several serological markers: HBsAg and anti-HBs, HBeAg and anti-

166 ayed across 6.5 years, supporting a model of serological memory based upon intrinsic longevity of hum

167 nsible for long-term antibody production and serological memory.

168 Standard typing procedures use serological or amplification-based assays performed sequ

169 G, a 3-dose regimen did not improve syphilis serological outcomes.

170 sion and assesses clinical, virological, and serological parameters of chikungunya disease severity.

171 y associated with nontransmission, different serological parameters were analyzed.

172 o establish the degree of similarity between serological patterns in ferret and human data.

173 ntial of HLA class I molecules helps explain serological patterns of alloantibody binding.

174 in splenic B cells, upregulation of RAG, and serological polyreactivity, suggestive of excessive rece

175 /2003 generated by rg (rgLegok/03) had lower serological potency (geometric mean HI titers, </= 1:95)

176 urkey/England/N28/1973 seed strains had high serological potency in chickens (geometric mean hemagglu

177 ue-invasive filarial infection increased the serological prevalence of ImmunoCAP-identified IgE direc

178 titis B virus (HBV) core antibody (anti-HBc) serological profile is frequent in human immunodeficienc

179 th HCV and displays a profile similar to the serological profile of HCV-infected persons, although th

180 ified synaptic autoantibodies may expand the serological profile of thymoma.

181 accination can be useful to distinguish this serological profile.

182 Here we investigated serological profiles against human and avian influenza v

183 Serological protection against one FMDV serotype does no

184 reviewed the clinical, electrophysiological, serological, radiological and pathological findings of p

185 evaluated the performances of commercialized serological rapid diagnostic tests (RDT) for T. cruzi in

186 l isolates to assess the uniformity of their serological reactions.

187 Amb p 5 and examined their correlation with serological reactivity and sequence conservation in othe

188 static potential reflected known patterns of serological reactivity better than Bw4/Bw6 amino acid se

189 ough a newly designed and implemented set of serological reagents, we used multiparameter flow cytome

190 He achieved complete clinical and serological remission and has remained symptom-free up t

191 rituximab who achieved complete clinical and serological remission.

192 l potential of middle-down UVPD for MS-based serological repertoire analysis.

193 The serological response (IgG) to SVA was evaluated by the w

194 may serve as a novel tool for prediction of serological response during polymerase inhibitor treatme

195 This serological response is compatible with acute, resolved,

196 interferon (Peg-IFN) to ETV therapy enhances serological response rates.

197 We investigated the human serological response to GAS impetigo in Fijian schoolchi

198 reveal unanticipated insights regarding the serological response to influenza vaccination and raise

199 STAT3 proteins in monocytes but not with the serological response to the vaccine.

200 esults reveal the nature and dynamics of the serological response to vaccination with direct implicat

201 ing B cells (ASCs) and its relationship with serological response, clinical parameters, and virologic

202 fering a glimpse of how dense phenotyping of serological responses coupled with bioinformatics analys

203 the course of EBOV infection and associated serological responses for patient-management decisions.

204 terium tuberculosis antigens associated with serological responses in tuberculosis patients.

205 who developed typhoid infection demonstrated serological responses to flagellin and lipopolysaccharid

206 ost studies of noroviruses having focused on serological responses to infection.

207 Similarly, the serological responses to seasonal influenza vaccination

208 s (HIV)-infected individuals may have poorer serological responses to syphilis treatment and may be m

209 the vaccine-induced plasmablast, memory, and serological responses to the trivalent influenza vaccine

210 To monitor the bait uptake and the serological responses to vaccination, foxes were shot by

211 hronic immunization induced antigen-specific serological responses with diverse SHM-mediated antibody

212 C responses correlated with systemic MBC and serological responses.

213 exposure has been associated with detectable serological responses.

214 All serological results were converted to international unit

215 1 were the best at resolving false-positive serological results.

216 nal allograft biopsy specimens confirmed the serological results.

217 c system, called mChip-Ld, using a set of 60 serological samples.

218 data demonstrate that antigens identified by serological screening are targets of multifunctional cel

219 Frequent serological screening of this population appears to be t

220 ustria, a country with a nationwide prenatal serological screening program since 1974.

221 s likely be detected in existing large-scale serological screening studies focused on well-establishe

222 cribed a biological drug (BD) have undergone serological screening to detect hepatitis B virus (HBV)

223 g the relationship between hantavirus NP and serological specificity and raising the potential for th

224 disease may include information on multiple serological states - naivete, recent infection, non-rece

225 st-effective, and early determination of the serological status of potentially infected individuals,

226 e fitted to estimate the effect of donor CMV serological status on outcome.

227 f MOG-IgG through a longitudinal analysis of serological status over a 2-year follow-up period.

228 seronegative, whereas a persistent positive serological status was observed in patients with clinica

229 g is determined by the interplay between HBV serological status, level of viremia, and the immunosupp

230 Additional epidemiological and serological studies are warranted to elucidate the dynam

231 Serological studies of human populations show a high pre

232 Initial serological studies were consistent with hepatitis A vir

233 including 4 new cases and 7 population-based serological studies, revealed significant increases in f

234 ics, ethnicity, cardiovascular risk factors, serological studies, socioeconomic status, left ventricu

235 cific properties typically requires detailed serological studies, which are rarely available in the e

236 An age-stratified serological study (n = 1,736) was conducted in 2010 amon

237 h Polynesia which closely matches a previous serological study; 20.8% (95% CI: 1.1-50.0%) in Colombia

238 Serological surveillance and vaccination are important s

239 valuating trachoma elimination programs, but serological surveillance can be a sensitive measure of d

240 Serological surveillance conducted in areas of an outbre

241 ity of pigs to IBV infection, we conducted a serological survey for U.S. Midwest domestic swine herds

242 y selected participants for a prevaccination serological survey in 2010 and a postvaccination survey

243 al information about novel infections before serological surveys and other detailed analyses are avai

244 Serological surveys provide reliable information from wh

245 ted for a limited set of locations for which serological surveys were available, the detection probab

246 of data available from both surveillance and serological surveys.

247 we evaluate the performance of a new leprosy serological test (NDO-LID).

248 m causing mycetoma is difficult; no reliable serological test exists but molecular techniques to iden

249 cial need for a rapid and sensitive in vitro serological test for BoNT/A to replace the current in vi

250 The current serological test for tularemia is based on agglutination

251 Serological test results for 451 patients with positive

252 eved using standardized and widely available serological test systems.

253 A simple and accurate serological test that is capable of detecting asymptomat

254 is assessed based on changes over months in serological test titres.

255 ng results are now available to Lyme disease serological test users and researchers developing novel

256 the urgent need for a specific and sensitive serological test.

257 test for microbial diagnosis, with directed serological testing (i.e., Q fever serology, Bartonella

258 revalence of HBV infection was determined by serological testing and analysis among noninstitutionali

259 his extended spectrum may enhance autoimmune serological testing as an aid to preoperative thymoma di

260 We performed serological testing for anti-HBs and microRNA-155 and as

261 We discuss the diagnostic value of serological testing for anti-PLA2R and tissue staining f

262 Serological testing for antibodies to Ct antigens is pot

263 Serological testing for KIR4.1-specific IgG is unlikely

264 Serological testing for Trypanosoma cruzi was performed

265 In Atlanta, serological testing identified a new virus.

266 PCR amplification and serological testing identified the infecting species as

267 2 or worse in HPV-naive subcohorts; however, serological testing methods and the HPV DNA criteria use

268 e the amount of resources spent on exclusive serological testing of vaccines and make wide spectrum v

269 gy-Hepatology- Nutrition Department, and the serological testing was performed at the Lyon-Sud Hospit

270 HPV serological testing was performed using competitive Lumi

271 on (PCR) amplification of blood samples, and serological testing were performed to identify the infec

272 Prior to serological testing, influenza viruses are typically pro

273 WDEIA in children cannot be ruled out by serological tests alone.

274 t incorporating rKR95 and rTR18 with rK39 in serological tests amenable to rapid or high-throughput s

275 e correlations among viruses and vaccines in serological tests and the power of HA sequence in predic

276 included comparing performance of different serological tests and to determine whether the suggested

277 In diagnosing celiac disease (CD), serological tests are highly valuable.

278 ven the lower sensitivity and specificity of serological tests in the aged population, clinical suspe

279 HLH and B. henselae through liver biopsy and serological tests led to the patient's recovery.

280 as increased the complexity of diagnosis, as serological tests may not distinguish between naturally

281 rt can serve as an example to prompt earlier serological tests to identify the aetiology in similar c

282 the hemagglutinin (HA) glycoprotein, classic serological tests used by surveillance laboratories indi

283 stations and difficulty in interpretation of serological tests used to confirm diagnosis and evaluate

284 Serological tests were also used for diagnosing dengue f

285 Serological tests were conducted on 3698 swine sera, inc

286 To diagnose celiac disease, serological tests were used, and duodenal biopsy samples

287 ed by the use of cost-effective confirmatory serological tests, similar standardized tools are not wi

288 etrospective studies, mostly on the basis of serological tests, with the problematic cross-reacting a

289 cant increase to the pre-test probability of serological tests.

290 transcription-polymerase chain reaction and serological tests.

291 lly infected, and of the cost per sample for serological tests.

292 eurosyphilis, and asymptomatic persons whose serological titers do not decline appropriately followin

293 INTERPRETATION: On the basis of decline in serological titre, oral single-dose azithromycin was eff

294 infection diagnostic testing (molecular and serological tools) used in the diagnosis and management

295 ds for the diagnosis of CT, with emphasis on serological tools.

296 Active immunization resulted in higher serological total IgG, IgG1, and IgG2a anti-alpha-syn le

297 ing a simple isolation protocol supported by serological tracking of ECA epitopes and NMR spectroscop

298 study, information on partially observed HIV serological values was supplemented by additional inform

299 nto analyses based on partially observed HIV serological values.

300 he same for all individuals with missing HIV serological values; the second assumed that the degree o